Traditional Medicinals

Traditional Medicinals, a US-based company in the Health and Social Work Services sector, reported its 2023 Scope 1 emissions as 59,340 kg CO2e, Scope 2 emissions as 34,340 kg CO2e, and Scope 3 emissions from employee commute as 928,000 kg CO2e. Data for Scope 3 'purchased goods and services' was not available for 2023.

In 2022, the company's Scope 1 emissions were 49,710 kg CO2e and Scope 2 emissions were 26,440 kg CO2e. For 2021, Scope 1 emissions were 61,560 kg CO2e and Scope 2 emissions were 23,840 kg CO2e. In 2020, Traditional Medicinals recorded 50,770 kg CO2e in Scope 1 emissions and 25,970 kg CO2e in Scope 2 emissions. Their 2019 Scope 1 emissions were 44,230 kg CO2e and Scope 2 emissions were 24,390 kg CO2e. In 2018, Scope 1 emissions were 64,680 kg CO2e and Scope 2 emissions were 18,620 kg CO2e. Scope 3 data was not available for the years prior to 2023.

Traditional Medicinals has set Science Based Targets initiative (SBTi) approved targets. The company commits to reduce its Scope 1 and Scope 2 greenhouse gas emissions by 42% by 2030 from a 2020 base year. Additionally, Traditional Medicinals aims to measure and reduce its Scope 3 emissions and achieve net-zero greenhouse gas emissions across its entire value chain by 2050 from a 2020 base year, which includes a 100% reduction in Scope 1, 2, and 3 emissions by 2050 from the same base year. These targets were approved using a streamlined validation route for small and medium-sized enterprises (SMEs).